In the Phase 2 retatrutide trial published in the New England Journal of Medicine (2023), participants at the highest dose (12 mg) achieved a mean body weight reduction of approximately 24.2% over 48 weeks
Research Context: Studied in preclinical research models examining: Peptidereceptor interactions Metabolic signaling mechanisms Hormonal pathway modulation Technical Information: Peptide Class: Synthetic peptide analogue Molecular Weight: ~4,100 Da (approximate, sequence-dependent) Form: Lyophilised powder Quantity: 20mg Note: Retatrutide is a multi-receptor peptide analogue
Decotiis, who was not involved in the study, said that liraglutide is not as effective as its newer cousins for weight loss or diabetes, and is not frequently used for these purposes
22% of Americans say they almost always (11%) or usually (11%) compare their body weight or size to others
It does not help you lose weight and should not be mistaken for a weight loss procedure
Many patients on GLP-1 therapy are eating less overall, which means dietary calcium intake may drop below the threshold needed for bone maintenance
&srotate=0)
